Stock DNA
Pharmaceuticals & Biotechnology
CNY 18,878 Million (Large Cap)
63.00
NA
0.00%
0.09
5.60%
5.22
Revenue and Profits:
Net Sales:
697 Million
(Quarterly Results - Mar 2026)
Net Profit:
72 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.2%
0%
-5.2%
6 Months
33.57%
0%
33.57%
1 Year
94.83%
0%
94.83%
2 Years
126.91%
0%
126.91%
3 Years
113.21%
0%
113.21%
4 Years
160.37%
0%
160.37%
5 Years
94.83%
0%
94.83%
Zhejiang Hengtong Holding Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
22.59%
EBIT Growth (5y)
11.94%
EBIT to Interest (avg)
-50.31
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.03
Sales to Capital Employed (avg)
0.27
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.13%
ROE (avg)
7.93%
Valuation key factors
Factor
Value
P/E Ratio
63
Industry P/E
Price to Book Value
3.65
EV to EBIT
-217.27
EV to EBITDA
154.35
EV to Capital Employed
3.52
EV to Sales
8.33
PEG Ratio
4.21
Dividend Yield
NA
ROCE (Latest)
-1.62%
ROE (Latest)
5.82%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
696.60
588.00
18.47%
Operating Profit (PBDIT) excl Other Income
-11.70
10.80
-208.33%
Interest
9.10
0.50
1,720.00%
Exceptional Items
14.90
25.10
-40.64%
Consolidate Net Profit
71.80
12.30
483.74%
Operating Profit Margin (Excl OI)
-16.80%
-41.40%
2.46%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 18.47% vs 32.55% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 483.74% vs -80.06% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,849.80
1,325.90
39.51%
Operating Profit (PBDIT) excl Other Income
101.60
88.60
14.67%
Interest
22.20
23.20
-4.31%
Exceptional Items
34.30
-23.90
243.51%
Consolidate Net Profit
200.90
165.60
21.32%
Operating Profit Margin (Excl OI)
-14.00%
-13.00%
-0.10%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 39.51% vs 105.22% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 21.32% vs 8.09% in Dec 2024
About Zhejiang Hengtong Holding Co., Ltd. 
Zhejiang Hengtong Holding Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






